Cargando…
miR-133b down-regulates ABCC1 and enhances the sensitivity of CRC to anti-tumor drugs
Multidrug resistance (MDR) is the main cause of failed chemotherapy treatments. Therefore, preventing MDR is pivotal in treating colorectal cancer (CRC). In a previous study miR-133b was shown to be a tumor suppressor. Additionally, in CRC cells transfected with miR-133b, ATP-binding cassette (ABC)...
Autores principales: | Chen, Miao, Li, Daojiang, Gong, Ni, Wu, Hao, Su, Chen, Xie, Canbin, Xiang, Hong, Lin, Changwei, Li, Xiaorong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581087/ https://www.ncbi.nlm.nih.gov/pubmed/28881788 http://dx.doi.org/10.18632/oncotarget.17677 |
Ejemplares similares
-
miR-133b, a particular member of myomiRs, coming into playing its unique pathological role in human cancer
por: Li, Daojiang, et al.
Publicado: (2017) -
Comprehensive analysis of differentially expressed profiles of lncRNAs and construction of miR-133b mediated ceRNA network in colorectal cancer
por: Wu, Hao, et al.
Publicado: (2017) -
Comparative study of joint bioinformatics analysis of underlying potential of ‘neurimmiR’, miR-212-3P/miR-132-3P, being involved in epilepsy and its emerging role in human cancer
por: Xia, Lu, et al.
Publicado: (2017) -
miR-9-5p Mediates ABCC1 to Elevate the Sensitivity of Glioma Cells to Temozolomide
por: Chen, Xiang-Rui, et al.
Publicado: (2021) -
[Corrigendum] DNA methylation is involved in the aberrant expression of miR‑133b in colorectal cancer cells
por: Lv, Lv, et al.
Publicado: (2023)